Mechanistic Evaluations of the Effects of Auranofin Triethylphosphine Replacement with a Trimethylphosphite Moiety

• Published in: Inorganic chemistry Vol. 62; no. 26; pp. 10389 - 10396
• Main Authors: Ronga, Luisa, Tolbatov, Iogann, Giorgi, Ester, Pisarek, Paulina, Enjalbal, Christine, Marrone, Alessandro, Tesauro, Diego, Lobinski, Ryszard, Marzo, Tiziano, Cirri, Damiano, Pratesi, Alessandro
• Format: Journal Article
• Language: English
• Published: United States American Chemical Society 03.07.2023
• Subjects: Analytical chemistry; Antineoplastic Agents - pharmacology; Auranofin - chemistry; Auranofin - pharmacology; Chemical Sciences; Gold - chemistry; Ligands; Magnetic Resonance Spectroscopy
• ISSN: 0020-1669; 1520-510X
• DOI: 10.1021/acs.inorgchem.3c01280

Auranofin, a gold­(I)-based complex, is under clinical trials for application as an anticancer agent for the treatment of nonsmall-cell lung cancer and ovarian cancer. In the past years, different derivatives have been developed, modifying gold linear ligands in the search for new gold complexes endowed with a better pharmacological profile. Recently, a panel of four gold­(I) complexes, inspired by the clinically established compound auranofin, was reported by our research group. As described, all compounds possess an [Au­{P­(OMe)3}]+ cationic moiety, in which the triethylphosphine of the parent compound auranofin was replaced with an oxygen-rich trimethylphosphite ligand. The gold­(I) linear coordination geometry was complemented by Cl–, Br–, I–, and the auranofin-like thioglucose tetraacetate ligand. As previously reported, despite their close similarity to auranofin, the panel compounds exhibited some peculiar and distinctive features, such as lower log P values which can induce relevant differences in the overall pharmacokinetic profiles. To get better insight into the P–Au strength and stability, an extensive study was carried out for relevant biological models, including three different vasopressin peptide analogues and cysteine, using 31P NMR and LC-ESI-MS. A DFT computational study was also carried out for a better understanding of the theoretical fundamentals of the disclosed differences with regard to triethylphosphine parent compounds.